Skip to main content

Table 1 PIK3CA mutation distribution in cervical cancer, breast cancer, and endometrial carcinoma

From: The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer

 

Cervical cancer (n = 990)

Breast cancer (n = 817)

Endometrial carcinoma (n = 248)

Amino acid change

No. of cases

Frequency of variants (%)

Amino acid change

No. of cases

Frequency of variants (%)

Amino acid change

No. of cases

Frequency of variants (%)

Exon 9 E542

E542K

43

4.3

E542K

30

3.7

E542K

9

3.6

   

E542G

2

0.2

E542A

2

0.8

      

E542Q

1

0.4

      

E542V

1

0.4

Total

43

4.3

Total

32

3.9

Total

13

5.2

Exon 9 E545

E545K

84

8.5

E545K

54

6.6

E545K

10

4.0

E545A

1

0.1

E542A

2

0.2

E545D

2

0.8

E545D

1

0.1

E545R

1

0.1

E545A

1

0.4

E545Q

1

0.1

   

E545G

1

0.4

Total

87

8.8

Total

57

7.0

Total

14

5.6

Exon 20 H1047

H1047R

5

0.5

H1047R

116

14.2

H1047R

12

4.8

H1047L

1

0.1

H1047L

11

1.3

H1047L

6

2.4

   

H1047Y

1

0.1

H1047Y

1

0.4

      

H1047Q

1

0.4

Total

6

0.6

Total

128

15.7

Total

20

8.1